Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin with Vosevi in HCV Non-responders
NCT04695769Phase 4Completed
- Sponsor
- Helwan University
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C (HCV), sponsored by Helwan University. Started Nov 2020; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04695769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04695769.